Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug
The U.S. district attorney for Massachusetts filed suit against the drugmaker this week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat macular degeneration.
